Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Blay J-Y, Schemann S and Favrot MC (1994) Local production of interleukin 6 by renal adenocarcinoma in vivo. J Natl Cancer Inst 86: 238
Dirix LY, Vermeulen PB, Hubens G, Benoy I, Martin M, De Pooter C and Van Oosterom AT (1996) Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal carcinoma. Ann Oncol 7: 843–848
Dirix LY, Vermeulen PB, Pawinsky A, Prové A, Benoy I, De Pooter C, Martin M and Van Oosterom AT (1997) Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 76: 238–243
Pinedo HM, Verheul HMW, D’Amato RJ and Folkman J (1998) Involvement of platelets in tumour angiogenesis?. Lancet 352: 1775–1777
Salven P, Teerenhovi L and Joensuu H (1997) A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin’s lymphoma. Blood 90: 3167–3172
Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E and Dirix LY (1999) Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer 80: 892–897
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Salgado, R., Benoy, I., Weytjens, R. et al. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients – reply. Br J Cancer 82, 1896 (2000). https://doi.org/10.1054/bjoc.1999.1253
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1253